撰文 | 唐东豪   责编 | 周叶斌在儿童肿瘤中，原发性肝癌（PLC）相对罕见，仅占所有儿童癌症的0.5%至1.5%。主要包括肝母细胞瘤（HB）和肝细胞癌（HCC）。而一种名为复合型肝细胞胆管癌（Combined ...

Current histopathological and anatomical methods of predicting outcome in early hepatocellular carcinoma (HCC ... patients with surgically resected, primary HCC. A validation set of samples ...

A cancer that starts in the liver is called primary liver cancer. There are several different types of primary liver cancer. The most common type is hepatocellular carcinoma, which begins in the main ...

Hepatocellular cancer, the most common form of primary liver cancer, is the fastest rising cause of cancer-related deaths in the United States. Texas has the highest incidence rates of HCC in the ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Tevimbra is under clinical development by BeiGene and currently in Phase II for Metastatic Hepatocellular Carcinoma (HCC).

SBRT showed superiority over radiofrequency ablation in local progression-free survival and tumor control in small HCC but ...

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Neuroendocrine Carcinoma.